PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Trial Profile

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs PG 2 (Primary)
  • Indications Fatigue
  • Focus Therapeutic Use
  • Sponsors PhytoHealth
  • Most Recent Events

    • 01 Aug 2017 Status changed from recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 09 May 2017 Planned number of patients changed from 250 to 350.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top